Chronic heartburn can lead to esophageal cancer
PromarkerEso provides a highly accurate rule out of esophageal cancer
PromarkerEso is a blood test developed for individuals with chronic reflux to identify their risk of esophageal cancer
Knowing your risk of esophageal cancer, in the presence of chronic reflux, helps you and your doctor better manage your health
Non-invasive and convenient detection
- test results can assist you and your doctor to take proactive steps to protect your health
Avoid delayed diagnosis
- Earlier identification through moderate/high risk results may enable less-invasive treatment of disease
Know your risk
- A blood test may avoid an endoscopic assessment entirely
3 easy steps to proactive peace of mind
- Step 1
Determine eligibility
Schedule a telehealth consultation to determine if you may be eligible to take this test
- Step 2
Get tested
Receive risk-based results, with a physician-supported discussion (moderate/high risk)
- Step 3
Informed decisions
With a low risk result, you and your physician can confidently continue management of your gastric reflux; while moderate/high risk results can support better clinical decisions
Earlier and more accessible detection is critical
For those suffering from chronic gastric reflux, esophageal cancer is often caught too late. The rising incidence of chronic reflux is leading to higher rates of this cancer. This test may help you and your doctor detect the presence of cancer quickly, to support better clinical management.

FAQs
The test is indicated for adults with no prior cancer diagnosis who exhibit at least two risk factors for EAC, including:
• Heartburn or Acid Reflux ((also known as GastroEsophageal Reflux Disease (GERD))
• Age > 50 years
• Overweight (BMI > 25 kg/m²)
Visit: www.myTEST.health
This test is available now in Australia via www.myTEST.health
Your PromarkerEso results indicate your risk of having esophageal cancer. The test gives a score that places you in one of three risk categories: low, moderate, or high. Low risk means your chance of presently having cancer is low; Moderate and High risk means the test has detected the presence of blood biomarkers indicating the presence of cancer. Your doctor will explain what your specific result means and help you decide the next steps to manage your health.
Clinical studies demonstrate the test rules out esophageal cancer at a 99.9% accuracy (NPV); while accurately detecting cancer (test sensitivity) at 91.4%
You can expect to receive your results in less than two weeks from blood collection.
Take the step towards peace of mind
Access the blood test that enables people with chronic reflux to determine their risk of esophageal cancer, by talking to your healthcare provider about the PromarkerEso test.